ch.oddb.org
 
Apotheken | Doctor | Drugs | Hospital | Interactions | MiGeL | Registration owner | Services
Home<List for "J07" (121)–Sort according to Concentration, Size and Price
     ProductPackage SizeEFPCPSBDCCompositionRegistr. HolderCategory    
What is an ATC-Code?ATC-Overview
Bacterial Vaccines (J07A) 2 products WHO-DDD 
Page 1 of 2: 12>>
  IPCIV/SDukoral PRPRk.A.Suspension und Brausepulver zur Herstellung einer Suspension zum Einnehmen: 5 Active AgentsBavarian Nordic Berna
GmbH		BGtell a friend
  IPCIV/SDukoral2PRPRk.A.Suspension und Brausepulver zur Herstellung einer Suspension zum Einnehmen: 5 Active AgentsBavarian Nordic Berna
GmbH		BGtell a friend
Cholera, Inactivated, Whole Cell (J07AE01) 2 products WHO-DDD DrugBank.ca
Page 1 of 2: 12>>
  IPCIV/SDukoral PRPRk.A.Suspension und Brausepulver zur Herstellung einer Suspension zum Einnehmen: 5 Active AgentsBavarian Nordic Berna
GmbH		BGtell a friend
  IPCIV/SDukoral2PRPRk.A.Suspension und Brausepulver zur Herstellung einer Suspension zum Einnehmen: 5 Active AgentsBavarian Nordic Berna
GmbH		BGtell a friend
Haemophilus Influenzae B, Purified Antigen Conjugated (J07AG01) 1 products WHO-DDD DrugBank.ca
Page 1 of 2: 12>>
L IP V/SHiberixSet(s)16.1634.0010 %Haemophilus Influenzae b Polysaccharida (Prp) 10 mcgGlaxoSmithKline AGB / SLGtell a friend
Meningococcus C, Purified Polysaccharides Antigen Conjugated (J07AH07) 1 products WHO-DDD DrugBank.ca
Page 1 of 2: 12>>
L IP V/SNeisVac-CFertigspritze(n)26.5045.2510 %Injection suspension: Polysaccharida Neisseriae Meningitidis c (Stamm C11, De-O-Acetyliert) 10µg / 0.5mlPfizer AGB / SLGtell a friend
Meningococcus A,C,Y,W-135, Tetravalent Purified Polysaccharides Antigen Conjugated (J07AH08) 3 products WHO-DDD DrugBank.ca
Page 1 of 2: 12>>
L IP V/SMenQuadfi 41.1561.1510 %Injection solution: 4 Active AgentsSanofi-Aventis
(Suisse) SA		B / SLGtell a friend
L IP V/SMenveoKombipackung(en)31.6950.9010 %Pulver und Lösung (Durchstechflaschen): Oligosaccharida Neisseriae Meningitidis A 10 µg
Pulver und Lösung (Durchstechflaschen): 3 Active Agents		GlaxoSmithKline AGB / SLGtell a friend
L IP V/SMenveo5 Kombipackung(en)158.4537.7510 %Pulver und Lösung (Durchstechflaschen): Oligosaccharida Neisseriae Meningitidis A 10 µg
Pulver und Lösung (Durchstechflaschen): 3 Active Agents		GlaxoSmithKline AGB / SLGtell a friend
Meningococcus B, Multicomponent Vaccine (J07AH09) 1 products WHO-DDD DrugBank.ca
Page 1 of 2: 12>>
L IP V/SBexsero 78.14101.4010 %Injection suspension: 4 Active AgentsGlaxoSmithKline AGB / SLGtell a friend
Pertussis, Purified Antigen, Combinations with Toxoids (J07AJ52) 5 products WHO-DDD DrugBank.ca
Page 1 of 2: 12>>
L IP V/SBoostrix 17.3035.2510 %3 Active AgentsGlaxoSmithKline AGB / SLGtell a friend
  IP V/SBoostrix10PRPRk.A.3 Active AgentsGlaxoSmithKline AGBGtell a friend
L IP V/SAdacel 0.5 ml0.5 ml18.7036.7510 %Sanofi-Aventis
(Suisse) SA		B / SLGtell a friend
  IP V/SAdacel 0.5 ml0.5 mlPRPRk.A.Sanofi-Aventis
(Suisse) SA		BGtell a friend
  IP V/SAdacel 0.5 ml10 x 0.5 mlPRPRk.A.Sanofi-Aventis
(Suisse) SA		BGtell a friend
Encephalitis, Tick Borne, Inactivated, Whole Virus (J07BA01) 8 products WHO-DDD DrugBank.ca
Page 1 of 2: 12>>
L IPCIV/SEncepur NFertigspritze(n) à 0.5 ml27.0045.8010 %Injection suspension: Virus fsme Inactivatus (Stamm K23) 1.5µg / 0.5mlBavarian Nordic Berna
GmbH		B / SLGtell a friend
L IP V/SEncepur N KinderFertigspritze(n) à 0.25 ml26.7945.5510 %Injection suspension: Virus fsme Inactivatus (Stamm K23) 0.75µg / 0.25mlBavarian Nordic Berna
GmbH		B / SLGtell a friend
L IP V/SEncepur N Kinder10 x 0.25 ml267.90307.7510 %Injection suspension: Virus fsme Inactivatus (Stamm K23) 0.75µg / 0.25mlBavarian Nordic Berna
GmbH		B / SLGtell a friend
L IP V/SFSME-Immun 0.25 ml JuniorFertigspritze(n)26.7945.5510 %Suspension zur intramuskulären Injektion: Virus fsme Inactivatus (Stamm Neudörfl.) 1.19µg / 0.25mlPfizer AGB / SLGtell a friend
L IP V/SFSME-Immun 0.25 ml Junior10 Fertigspritze(n)267.90307.7510 %Suspension zur intramuskulären Injektion: Virus fsme Inactivatus (Stamm Neudörfl.) 1.19µg / 0.25mlPfizer AGB / SLGtell a friend
L IP V/SFSME-Immun CCFertigspritze(n)27.0045.8010 %Suspension zur intramuskulären Injektion: Virus fsme Inactivatus (Stamm Neudörfl.) 2.4µg / 0.5mlPfizer AGB / SLGtell a friend
  IPCIV/SEncepur N10 x 0.5 mlPRPRk.A.Injection suspension: Virus fsme Inactivatus (Stamm K23) 1.5µg / 0.5mlBavarian Nordic Berna
GmbH		BGtell a friend
  IP V/SFSME-Immun CC10 Fertigspritze(n)PRPRk.A.Suspension zur intramuskulären Injektion: Virus fsme Inactivatus (Stamm Neudörfl.) 2.4µg / 0.5mlPfizer AGBGtell a friend
Encephalitis, Japanese, Inactivated, Whole Virus (J07BA02) 1 products WHO-DDD DrugBank.ca
Page 1 of 2: 12>>
  IP V/SIXIAROsyringe(s)PRPRk.A.Injection suspension: Enzephalitidis Japanensis viri Antigenum (Stamm: Sa-14-2) 6U. / 0.5mlBavarian Nordic Berna
GmbH		BGtell a friend
Influenza, Inactivated, Split Virus Or Surface Antigen (J07BB02) 31 products WHO-DDD DrugBank.ca
Page 1 of 2: 12>>
L IP V/SFluarix Tetra 15 µg / 0.5 ml 9.5826.8510 %GlaxoSmithKline AGB / SLGtell a friend
L IP V/SInfluvac Tetra 0.5 ml 9.5826.8510 %Viatris Pharma GmbHB / SLGtell a friend
L IP V/SVaxigripTetra 9.5826.8510 %Sanofi-Aventis
(Suisse) SA		B / SLGtell a friend
  IP V/SFlucelvax Tetra 9.5826.8510 %Injection suspension: 3 Active AgentsVifor (International) AGB / SLGtell a friend
L IP V/SEfluelda 0.7 ml 31.0048.8010 %suspension injectable en seringue préremplie: 3 Active AgentsSanofi-Aventis
(Suisse) SA		B / SLGtell a friend
  IP V/SFluarix Tetra 15 µg / 0.5 ml10PRPRk.A.GlaxoSmithKline AGBGtell a friend
  IP V/SInfluvac Tetra 0.5 ml10PRPRk.A.Viatris Pharma GmbHBGtell a friend
    V/SVaxigrip PRPRk.A.Sanofi-Aventis
(Suisse) SA		BGtell a friend
    V/SVaxigrip10PRPRk.A.Sanofi-Aventis
(Suisse) SA		BGtell a friend
  IP V/SVaxigripTetra PRPRk.A.Sanofi-Aventis
(Suisse) SA		BGtell a friend
  IP V/SVaxigripTetra10PRPRk.A.Sanofi-Aventis
(Suisse) SA		BGtell a friend
  IP V/SVaxigripTetra10PRPRk.A.Sanofi-Aventis
(Suisse) SA		BGtell a friend
  IP V/SFlucelvax Tetra PRPRk.A.Injection suspension: 3 Active AgentsVifor (International) AGBGtell a friend
  IP V/SFlucelvax Tetra10PRPRk.A.Injection suspension: 3 Active AgentsVifor (International) AGBGtell a friend
  IP V/SFlucelvax Tetra10PRPRk.A.Injection suspension: 3 Active AgentsVifor (International) AGBGtell a friend
    V/SEfluelda TIV 0.5 mL PRPRk.A.suspension injectable en seringue pré-remplie: 3 Active AgentsSanofi-Aventis
(Suisse) SA		BGtell a friend
    V/SEfluelda TIV 0.5 mL10PRPRk.A.suspension injectable en seringue pré-remplie: 3 Active AgentsSanofi-Aventis
(Suisse) SA		BGtell a friend
  IP V/SEfluelda 0.7 ml PRPRk.A.suspension injectable en seringue préremplie: 3 Active AgentsSanofi-Aventis
(Suisse) SA		BGtell a friend
  IP V/SEfluelda 0.7 ml5PRPRk.A.suspension injectable en seringue préremplie: 3 Active AgentsSanofi-Aventis
(Suisse) SA		BGtell a friend
  IP V/SEfluelda 0.7 ml5PRPRk.A.suspension injectable en seringue préremplie: 3 Active AgentsSanofi-Aventis
(Suisse) SA		BGtell a friend
  IP V/SEfluelda 0.7 ml10PRPRk.A.suspension injectable en seringue préremplie: 3 Active AgentsSanofi-Aventis
(Suisse) SA		BGtell a friend
  IP V/SEfluelda 0.7 ml10PRPRk.A.suspension injectable en seringue préremplie: 3 Active AgentsSanofi-Aventis
(Suisse) SA		BGtell a friend
  IP V/SFoclivia PRPRk.A.Vifor (International) AGBGtell a friend
  IP V/SFoclivia10PRPRk.A.Vifor (International) AGBGtell a friend
  IP V/SFoclivia10PRPRk.A.Vifor (International) AGBGtell a friend
L IP V/SInfluvacFertigspritze(n) à 0.5 ml9.1018.65k.A.Injection suspension: 3 Active AgentsMylan Pharma GmbHB / SLGtell a friend
  IP V/SInfluvacFertigspritze(n) à 0.5 ml9.1018.65k.A.Mylan Pharma GmbHBGtell a friend
  IP V/SInfluvac10 1 Fertigspritze(n) à 0.5 mlPRPRk.A.Mylan Pharma GmbHBGtell a friend
  IP V/SInfluvac10 1 Fertigspritze(n) à 0.5 mlPRPRk.A.Injection suspension: 3 Active AgentsMylan Pharma GmbHBGtell a friend
  IP V/SOptaflu0.5 ml10.0519.70k.A.Vaccinum Influenzae Inactivatum ex Corticis Antigeniis Praeparatum (Cellulae Mdck) 2015/2016Novartis Pharma
Schweiz AG		BGtell a friend
  IP V/SMutagrip0.5 ml8.5117.95k.A.Vaccinum Influenzae-Split, Inactivatum 2018/2019Sanofi-Aventis
(Suisse) SA		BGtell a friend
Hepatitis B, Purified Antigen (J07BC01) 8 products WHO-DDD DrugBank.ca
Page 1 of 2: 12>>
L IP V/SEngerix-B 10 20.8339.0510 %Injection suspension: Hepatitidis b viri Antigenum Adnr 10µg / 0.5mlGlaxoSmithKline AGB / SLGtell a friend
L IP V/SEngerix-B 20 23.6642.1510 %Injection suspension: Hepatitidis b viri Antigenum Adnr 20 µg/mlGlaxoSmithKline AGB / SLGtell a friend
  IP V/SEngerix-B 2010PRPRk.A.Injection suspension: Hepatitidis b viri Antigenum Adnr 20 µg/mlGlaxoSmithKline AGBGtell a friend
L IP V/SHBVAXPRO 10Fertigspritze(n) à 1 ml25.2343.8510 %Injection suspension: Hepatitidis b viri Antigenum Adnr 10 µg/mlMSD Merck Sharp &
Dohme AG		B / SLGtell a friend
L IP V/SHBVAXPRO 1010 1 Fertigspritze(n) à 1 ml252.30290.8010 %Injection suspension: Hepatitidis b viri Antigenum Adnr 10 µg/mlMSD Merck Sharp &
Dohme AG		B / SLGtell a friend
L IP V/SHBVAXPRO 40ampoule(s)42.0962.2010 %Injection suspension: Hepatitidis b viri Antigenum Adnr 40 µg/mlMSD Merck Sharp &
Dohme AG		B / SLGtell a friend
  IP V/SHBVAXPRO 10Durchstechflasche(n) à 1 mlPRPRk.A.Injection suspension: Hepatitidis b viri Antigenum Adnr 10 µg/mlMSD Merck Sharp &
Dohme AG		BGtell a friend
  IP V/SHBVAXPRO 5ampoule(s)22.4242.10k.A.Injection suspension: Hepatitidis b Virus Antigenum Adnr 5 µgSanofi Pasteur MSD AGBGtell a friend
Hepatitis A, Inactivated, Whole Virus (J07BC02) 2 products WHO-DDD DrugBank.ca
Page 1 of 2: 12>>
L IP V/SHavrix 720 22.4840.8510 %Injection suspension: Hepatitis-A-Virus Inactivatus (Hm175) 720U. / 0.5mlGlaxoSmithKline AGB / SLGtell a friend
L IP V/SHavrix 1440 31.8451.0510 %Injection suspension: Hepatitis-A-Virus Inactivatus (Hm175) 1440 U/mlGlaxoSmithKline AGB / SLGtell a friend
Combinations (J07BC20) 2 products WHO-DDD 
Page 1 of 2: 12>>
  IP V/STwinrix 720/20 PRPRk.A.Injection suspension: 2 Active AgentsGlaxoSmithKline AGBGtell a friend
  IP V/STwinrix 720/2010PRPRk.A.Injection suspension: 2 Active AgentsGlaxoSmithKline AGBGtell a friend
Measles, Combinations with Mumps and Rubella, Live Attenuated (J07BD52) 4 products WHO-DDD DrugBank.ca
Page 1 of 2: 12>>
L IP V/SM-M-RVAXPROampoule(s)18.6836.7510 %Lyophilisate and solvent: 3 Active AgentsMSD Merck Sharp &
Dohme AG		B / SLGtell a friend
L IP V/SM-M-RVAXPRO10 ampoule(s)186.80219.5510 %Lyophilisate and solvent: 3 Active AgentsMSD Merck Sharp &
Dohme AG		B / SLGtell a friend
L IP V/SPriorixKombipackung(en)17.5735.5010 %Lyophilisate and solvent: 3 Active AgentsGlaxoSmithKline AGB / SLGtell a friend
  IP V/SPriorix10 Kombipackung(en)PRPRk.A.Lyophilisate and solvent: 3 Active AgentsGlaxoSmithKline AGBGtell a friend
Measles, Combinations with Mumps, Rubella and Varicella, Live Attenuated (J07BD54) 3 products WHO-DDD DrugBank.ca
Page 1 of 2: 12>>
L IP V/SProQuadDurchstechflasche(n)63.9986.0010 %4 Active AgentsMSD Merck Sharp &
Dohme AG		B / SLGtell a friend
L IP V/SProQuad10 Durchstechflasche(n)639.90712.3510 %4 Active AgentsMSD Merck Sharp &
Dohme AG		B / SLGtell a friend
L IP V/SPriorix-TetraDurchstechflasche(n)66.6988.9510 %Lyophilisate and solvent: 4 Active Agents
Lyophilisate and solvent: 4 Active Agents		GlaxoSmithKline AG● B / SLGtell a friend
Yellow Fever, Live Attenuated (J07BL01) 1 products WHO-DDD 
Page 1 of 2: 12>>
  IP V/SStamarilDurchstechflasche(n)PRPRk.A.poudre et solvant pour suspension injectable: Virus Febris Flavae Vivus (Souche 17 D-204) 1000 USanofi-Aventis
(Suisse) SA		AGtell a friend
Papillomavirus (Human Types 6, 11, 16, 18, 31, 33, 45, 52, 58) (J07BM03) 2 products WHO-DDD DrugBank.ca
Page 1 of 2: 12>>
  IP V/SPPGardasil 9 PRPRk.A.Injektionssuspension in Fertigspritze: 9 Active AgentsMSD Merck Sharp &
Dohme AG		BGtell a friend
  IP V/SPPGardasil 910PRPRk.A.Injektionssuspension in Fertigspritze: 9 Active AgentsMSD Merck Sharp &
Dohme AG		BGtell a friend
Other Viral Vaccines (J07BX) 5 products WHO-DDD 
Page 1 of 2: 12>>
L IPCIV/SSpikevax JN.1 (mRNA-
1273.167), 0.10mg/ml		 74.7296.4510 %Moderna Switzerland
GmbH		B / SLGtell a friend
L IPCIV/SSpikevax JN.1 (mRNA-
1273.167), 0.10mg/ml		10747.20816.5510 %Moderna Switzerland
GmbH		B / SLGtell a friend
  IP V/SJynneos20PRPRk.A.Bavarian Nordic
Switzerland AG		BGtell a friend
  IPCIV/SmResvia Respiratorisches-
Synzytial-Virus (RSV)
Vakzin 0.10 mg/ml		 PRPRk.A.Moderna Switzerland
GmbH		BGtell a friend
  IPCIV/SmResvia Respiratorisches-
Synzytial-Virus (RSV)
Vakzin 0.10 mg/ml		10PRPRk.A.Moderna Switzerland
GmbH		BGtell a friend
Ebola Vaccines (J07BX02) 1 products WHO-DDD DrugBank.ca
Page 1 of 2: 12>>
  IP V/SErvebo10PRPRk.A.MSD Merck Sharp &
Dohme AG		BGtell a friend
Dengue Virus Vaccines (J07BX04) 1 products WHO-DDD 
Page 1 of 2: 12>>
  IP V/SQdenga 0.5 ml PRPRk.A.Takeda Pharma AGBGtell a friend
Diphtheria-Poliomyelitis-Tetanus (J07CA01) 2 products WHO-DDD DrugBank.ca
Page 1 of 2: 12>>
L IP V/SRevaxis 11.8629.3010 %Injection suspension: 2 Active AgentsSanofi-Aventis
(Suisse) SA		B / SLGtell a friend
  IP V/SRevaxis10PRPRk.A.Injection suspension: 2 Active AgentsSanofi-Aventis
(Suisse) SA		BGtell a friend
Diphtheria-Pertussis-Poliomyelitis-Tetanus (J07CA02) 10 products WHO-DDD DrugBank.ca
Page 1 of 2: 12>>
L IP V/SBoostrix Polio 24.8643.4510 %4 Active AgentsGlaxoSmithKline AGB / SLGtell a friend
L IP V/SInfanrix DTPa-IPV 20.2038.4010 %8 Active AgentsGlaxoSmithKline AGB / SLGtell a friend
L IP V/STetravac 20.2138.4010 %Injection suspension: 2 Active AgentsSanofi-Aventis
(Suisse) SA		B / SLGtell a friend
  IP V/SBoostrix Polio10PRPRk.A.4 Active AgentsGlaxoSmithKline AGBGtell a friend
L IP V/SAdacel-Polio 0.5 ml0.5 ml24.0042.5010 %Sanofi-Aventis
(Suisse) SA		B / SLGtell a friend
  IP V/SAdacel-Polio 0.5 ml0.5 mlPRPRk.A.Sanofi-Aventis
(Suisse) SA		BGtell a friend
  IP V/SAdacel-Polio 0.5 ml0.5 mlPRPRk.A.Sanofi-Aventis
(Suisse) SA		BGtell a friend
  IP V/SAdacel-Polio 0.5 ml10 x 0.5 mlPRPRk.A.Sanofi-Aventis
(Suisse) SA		BGtell a friend
  IP V/SAdacel-Polio 0.5 ml10 x 0.5 mlPRPRk.A.Sanofi-Aventis
(Suisse) SA		BGtell a friend
  IP V/SAdacel-Polio 0.5 ml10 x 5 mlPRPRk.A.Sanofi-Aventis
(Suisse) SA		BGtell a friend
Diphtheria-Haemophilus Influenzae B-Pertussis-Poliomyelitis-Tetanus (J07CA06) 2 products WHO-DDD DrugBank.ca
Page 1 of 2: 12>>
L IP V/SInfanrix DTPa-IPV+Hib 34.3253.7510 %Pulver und Suspension zur Herstellung einer Injektionssuspension: 8 Active AgentsGlaxoSmithKline AGB / SLGtell a friend
L IP V/SPentavacDurchstechflasche(n)34.1953.6010 %Poudre et suspension pour suspension injectable: 2 Active AgentsSanofi-Aventis
(Suisse) SA		B / SLGtell a friend
Diphtheria-Haemophilus Influenzae B-Pertussis-Poliomyelitis-Tetanus-Hepatitis B (J07CA09) 5 products WHO-DDD DrugBank.ca
Page 1 of 2: 12>>
L IP V/SInfanrix hexa 51.6672.6010 %Injection suspension: 9 Active AgentsGlaxoSmithKline AGB / SLGtell a friend
  IP V/SInfanrix hexa10 x 1PRPRk.A.Injection suspension: 9 Active AgentsGlaxoSmithKline AGBGtell a friend
L IP V/SVaxelis 0.5 ml 51.1472.0510 %Injection suspension: 10 Active AgentsFuture Health Pharma
GmbH		B / SLGtell a friend
  IP V/SVaxelis 0.5 ml10PRPRk.A.Injection suspension: 10 Active AgentsFuture Health Pharma
GmbH		BGtell a friend
  IP V/SVaxelis 0.5 ml10PRPRk.A.Injection suspension: 10 Active AgentsFuture Health Pharma
GmbH		BGtell a friend
 
ATC-Browser | Drugs A-Z | Recent Registrations
2025 ©ywesee GmbH
Settings | Help | FAQ | Login | Contact | Home